Monosomy 3 by FISH in Uveal Melanoma: Variability in Techniques and Results

Survey of Ophthalmology

Volumn 57, Issue 5, 2012, Pages 463-473

  Aronow, Mary ^a   Sun, Yang ^a   Saunthararajah, Yogen ^b   Biscotti, Charles ^a   Tubbs, Raymond ^a   Triozzi, Pierre ^b   Singh, Arun D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Fluorescence in situ hybridization (FISH); Monosomy 3; Tumor; Uveal melanoma

Indexed keywords

ASPIRATION BIOPSY; CANCER PROGNOSIS; CANCER TISSUE; CELL COUNT; CHROMOSOME ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FORMALIN FIXED PARAFFIN EMBEDDED TISSUE; FRESH TISSUE; GENE PROBE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; METASTASIS; MONOSOMY; MONOSOMY 3; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; SAMPLING; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UVEA MELANOMA;

CHROMOSOMES, HUMAN, PAIR 3; DNA PROBES; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOMA; MONOSOMY; UVEAL NEOPLASMS;

EID: 84865190272     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2011.12.004     Document Type: Review

References (58)

1. Bauer J., Kilic E., Vaarwater J., et al. Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer 2009, 101:813-815.
2. Bonaldi L., Midena E., Filippi B., et al. FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J Cancer Res Clin Oncol 2008, 134:1123-1127.
3. Bronkhorst I.H., Maat W., Jordanova E.S., et al. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Arch Pathol Lab Med 2011, 135:1042-1047.
4. Group COMS Group. COMS Manual of Procedures. Accession no. PBS 179693. Springfield, VA, National Technical Information Service, 1995. Available at . Accessed March 2, 2012. http://www.jhu.edu/wctb/coms/index.htm.
5. Cook J.R. Fluorescence in situ hybridization. Cell and Tissue Based Molecular Pathology, Vol. 1 2009, 104-113. Churchill Livingstone, Philadelphia, PA. R.R. Tubbs, M.H. Stoler (Eds.).
6. Cools D., Debiec-Rychter M., Parys-Van Ginderdeuren R., et al. Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma. Bull Soc Belge Ophtalmol 2000, 278:67-70.
7. Coupland S.E., Campbell I., Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology 2008, 115:1778-1785.
8. Cross N.A., Ganesh A., Parpia M., et al. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Eye (Lond) 2006, 20:476-481.
9. Damato B., Coupland S.E. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye (Lond) 2009, 23:2152-2160. quiz 2161-2.
10. Damato B., Dopierala J., Klaasen A., et al. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci 2009, 50:3048-3055.
11. Damato B., Dopierala J.A., Coupland S.E. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 2010, 16:6083-6092.
12. Damato B., Duke C., Coupland S.E., et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 2007, 114:1925-1931.
13. Dopierala J., Damato B.E., Lake S.L., et al. Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci 2010, 51:4898-4905.
14. Folberg R., Pe'er J. Uveal malignant melanoma: prognostic factors. Clinical Ophthalmic Oncology, Vol. 1 2007, 272-276. Saunders-Elsevier, Philadelphia, PA. A.D. Singh, B. Damato, J. Pe'er (Eds.).
15. Griffin C.A., Long P.P., Schachat A.P. Trisomy 6p in an ocular melanoma. Cancer Genet Cytogenet 1988, 32:129-132.
16. Harbour J.W. Molecular prognostic testing in uveal melanoma: has it finally come of age?. Arch Ophthalmol 2007, 125:1122-1123.
17. Horsman D.E., Sroka H., Rootman J., et al. Monosomy 3 and isochromosome 8q in a uveal melanoma. Cancer Genet Cytogenet 1990, 45:249-253.
18. Horsthemke B., Prescher G., Bornfeld N., et al. Loss of chromosome 3 alleles and multiplication of chromosome 8 alleles in uveal melanoma. Genes Chromosomes Cancer 1992, 4:217-221.
19. Hughes S., Damato B.E., Giddings I., et al. Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3. Br J Cancer 2005, 93:1191-1196.
20. Kilic E., Naus N.C., van Gils W., et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci 2005, 46:2253-2257.
21. Kilic E., van Gils W., Lodder E., et al. Clinical and cytogenetic analyses in uveal melanoma. Invest Ophthalmol Vis Sci 2006, 47:3703-3707.
22. Lake S.L., Coupland S.E., Taktak A.F., et al. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci 2010, 51:4884-4891.
23. Maat W., Jordanova E.S., van Zelderen-Bhola S.L., et al. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med 2007, 131:91-96.
24. Maat W., Ly L.V., Jordanova E.S., et al. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Invest Ophthalmol Vis Sci 2008, 49:505-510.
25. Marathe O.S., Wu J., Lee S.P., et al. Ocular response of choroidal melanoma with monosomy 3 versus disomy 3 after iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 2011, 81:1046-1048.
26. McNamara M., Felix C., Davison E.V., et al. Assessment of chromosome 3 copy number in ocular melanoma using fluorescence in situ hybridization. Cancer Genet Cytogenet 1997, 98:4-8.
27. Mensink H.W., Vaarwater J., Kilic E., et al. Chromosome 3 intratumor heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci 2009, 50:500-504.
28. Midena E., Bonaldi L., Parrozzani R., et al. In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up. Graefes Arch Clin Exp Ophthalmol 2008, 246:609-614.
29. Midena E., Bonaldi L., Parrozzani R., et al. In vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy. Eur J Ophthalmol 2006, 16:422-425.
30. Mudhar H.S., Saunders E., Rundle P., et al. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma. Br J Ophthalmol 2009, 93:535-540.
31. Naus N.C., Verhoeven A.C., van Drunen E., et al. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Clin Cancer Res 2002, 8:534-539.
32. Onken M.D., Worley L.A., Person E., et al. Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res 2007, 13:2923-2927.
33. Parrella P., Fazio V.M., Gallo A.P., et al. Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res 2003, 63:8507-8510.
34. Patel K.A., Edmondson N.D., Talbot F., et al. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Br J Ophthalmol 2001, 85:1440-1444.
35. Prescher G., Bornfeld N., Hirche H., et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996, 347:1222-1225.
36. Prescher G., Bornfeld N., Horsthemke B., Becher R. Chromosomal aberrations defining uveal melanoma of poor prognosis. Lancet 1992, 339:691-692.
37. Radhakrishnan A., Badhrinarayanan N., Biswas J., et al. Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma. Mol Vis 2009, 15:2146-2154.
38. Sandinha M.T., Farquharson M.A., McKay I.C., et al. Monosomy 3 predicts death but not time until death in choroidal melanoma. Invest Ophthalmol Vis Sci 2005, 46:3497-3501.
39. Sandinha M.T., Farquharson M.A., Roberts F. Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation. Br J Ophthalmol 2004, 88:1527-1532.
40. Sandinha T., Farquharson M., McKay I., et al. Correlation of heterogeneity for chromosome 3 copy number with cell type in choroidal melanoma of mixed-cell type. Invest Ophthalmol Vis Sci 2006, 47:5177-5180.
41. Schoenfield L., Pettay J., Tubbs R.R., et al. Variation of monosomy 3 status within uveal melanoma. Arch Pathol Lab Med 2009, 133:1219-1222.
42. Shields C.L., Ganguly A., Materin M.A., et al. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Arch Ophthalmol 2007, 125:1017-1024.
43. Shields J.A., Shields C.L., Materin M., et al. Role of cytogenetics in management of uveal melanoma. Arch Ophthalmol 2008, 126:416-419.
44. Singh A.D., Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 2003, 110:956-961.
45. Singh A.D., Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 2003, 110:962-965.
46. Sisley K., Cottam D.W., Rennie I.G., et al. Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma. Genes Chromosomes Cancer 1992, 5:197-200.
47. Sisley K., Nichols C., Parsons M.A., et al. Clinical applications of chromosome analysis, from fine needle aspiration biopsies, of posterior uveal melanomas. Eye (Lond) 1998, 12(Pt 2):203-207.
48. Sisley K., Parsons M.A., Garnham J., et al. Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma. Br J Cancer 2000, 82:330-338.
49. Sisley K., Rennie I.G., Cottam D.W., et al. Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer 1990, 2:205-209.
50. Sisley K., Rennie I.G., Parsons M.A., et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 1997, 19:22-28.
51. Tschentscher F., Prescher G., Horsman D.E., et al. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res 2001, 61:3439-3442.
52. Turell ME, Tubbs RR, Sun Y, et al. FISH-based prognostication of uveal melanoma: The 2011 Annual Association for Research in Vision and Ophthalmology Meeting. Fort Lauderdale, FL 2011, pp 1435-D1734.
53. van Gils W., Lodder E.M., Mensink H.W., et al. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis. Invest Ophthalmol Vis Sci 2008, 49:4254-4262.
54. White J.S., Becker R.L., McLean I.W., et al. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines. Cancer Genet Cytogenet 2006, 168:11-21.
55. White V.A., McNeil B.K., Horsman D.E. Acquired homozygosity (isodisomy) of chromosome 3 in uveal melanoma. Cancer Genet Cytogenet 1998, 102:40-45.
56. Worley L.A., Onken M.D., Person E., et al. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res 2007, 13:1466-1471.
57. Young T.A., Burgess B.L., Rao N.P., et al. Transscleral fine-needle aspiration biopsy of macular choroidal melanoma. Am J Ophthalmol 2008, 145:297-302.
58. Young T.A., Burgess B.L., Rao N.P., et al. High-density genome array is superior to fluorescence in situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy. Mol Vis 2007, 13:2328-2333.